心肌肌钙蛋白I和T在免疫检查点抑制剂相关性心肌炎的筛查、诊断及预后中的应用 - Suppr

Suppr

超能文献

Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis.

作者信息

Barac Ana, Wadlow Raymond C, Deeken John F, deFilippi Christopher

机构信息

Inova Schar Heart and Vascular, Fairfax, Virginia, USA.

Inova Schar Cancer, Fairfax, Virginia, USA.

出版信息

JACC CardioOncol. 2024 Aug 6;6(5):804-807. doi: 10.1016/j.jaccao.2024.07.001. eCollection 2024 Oct.

DOI:10.1016/j.jaccao.2024.07.001

PMID:39479330

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520212/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/be78/11520212/e07e9b7286dd/ga1.jpg

相似文献

Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis.

JACC CardioOncol. 2024 Aug 6;6(5):804-807. doi: 10.1016/j.jaccao.2024.07.001. eCollection 2024 Oct.

Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.

Cancer Med. 2024 May;13(10):e7233. doi: 10.1002/cam4.7233.

Prospective cardiovascular events in patients with advanced thoracic cancer treated with immune checkpoint inhibitor.

Eur J Cancer. 2024 Aug;207:114191. doi: 10.1016/j.ejca.2024.114191. Epub 2024 Jun 24.

Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution.

Int Immunopharmacol. 2024 Jul 30;136:112385. doi: 10.1016/j.intimp.2024.112385. Epub 2024 Jun 7.

Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.

Curr Cardiol Rep. 2023 Sep;25(9):959-967. doi: 10.1007/s11886-023-01915-5. Epub 2023 Jul 12.

Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.

Radiology. 2022 Jun;303(3):512-521. doi: 10.1148/radiol.211765. Epub 2022 Mar 1.

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Circulation. 2023 Aug 8;148(6):473-486. doi: 10.1161/CIRCULATIONAHA.123.062405. Epub 2023 Jun 15.

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.

Cell Rep. 2022 Nov 8;41(6):111611. doi: 10.1016/j.celrep.2022.111611.

Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis.

JACC Cardiovasc Imaging. 2022 Nov;15(11):1883-1896. doi: 10.1016/j.jcmg.2022.06.014. Epub 2022 Sep 14.

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19.

引用本文的文献

Multimodal Imaging of Immune Checkpoint Inhibitor Myocarditis.

J Clin Med. 2025 Apr 21;14(8):2850. doi: 10.3390/jcm14082850.

Immune Checkpoint Inhibitor-Related Myocarditis, Myopathy, and More: Unraveling the Tangled Science of Immune-Related Adverse Events.

JACC CardioOncol. 2025 Apr;7(3):265-267. doi: 10.1016/j.jaccao.2025.03.004.

Immune Checkpoint Inhibitor-Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes.

JACC CardioOncol. 2025 Apr;7(3):252-264. doi: 10.1016/j.jaccao.2025.02.005. Epub 2025 Mar 17.

Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population.

Ther Clin Risk Manag. 2025 Feb 3;21:125-135. doi: 10.2147/TCRM.S477417. eCollection 2025.

本文引用的文献

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach.

Front Cardiovasc Med. 2024 Feb 12;11:1350585. doi: 10.3389/fcvm.2024.1350585. eCollection 2024.

High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific.

JACC CardioOncol. 2023 Oct 17;5(5):610-612. doi: 10.1016/j.jaccao.2023.09.001. eCollection 2023 Oct.

Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral Vision.

Circulation. 2023 Oct 10;148(15):1135-1137. doi: 10.1161/CIRCULATIONAHA.123.065988. Epub 2023 Oct 9.

Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?

Eur Heart J. 2023 Jul 21;44(28):2606-2608. doi: 10.1093/eurheartj/ehad414.

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Circulation. 2023 Aug 8;148(6):473-486. doi: 10.1161/CIRCULATIONAHA.123.062405. Epub 2023 Jun 15.

High-sensitivity troponins and mortality in the general population.

Eur Heart J. 2023 Jul 21;44(28):2595-2605. doi: 10.1093/eurheartj/ehad328.

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: State-of-the-Art Review.

JACC CardioOncol. 2022 Dec 20;4(5):579-597. doi: 10.1016/j.jaccao.2022.09.004. eCollection 2022 Dec.

Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.

JACC CardioOncol. 2022 Dec 20;4(5):689-700. doi: 10.1016/j.jaccao.2022.11.004. eCollection 2022 Dec.

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: State-of-the-Art Review.

JACC CardioOncol. 2022 Dec 20;4(5):598-615. doi: 10.1016/j.jaccao.2022.11.011. eCollection 2022 Dec.

Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.

Circulation. 2022 Jun 14;145(24):1764-1779. doi: 10.1161/CIRCULATIONAHA.121.058489. Epub 2022 Apr 7.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis.

作者信息

Barac Ana, Wadlow Raymond C, Deeken John F, deFilippi Christopher

机构信息

Inova Schar Heart and Vascular, Fairfax, Virginia, USA.

Inova Schar Cancer, Fairfax, Virginia, USA.

出版信息

JACC CardioOncol. 2024 Aug 6;6(5):804-807. doi: 10.1016/j.jaccao.2024.07.001. eCollection 2024 Oct.

DOI:10.1016/j.jaccao.2024.07.001

PMID:39479330

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11520212/

Abstract

摘要

相似文献

Cardiac Troponin I and T in ICI Myocarditis Screening, Diagnosis, and Prognosis.

JACC CardioOncol. 2024 Aug 6;6(5):804-807. doi: 10.1016/j.jaccao.2024.07.001. eCollection 2024 Oct.

Cardiovascular adverse events associated with immune checkpoint inhibitors: A retrospective multicenter cohort study.

Cancer Med. 2024 May;13(10):e7233. doi: 10.1002/cam4.7233.

Prospective cardiovascular events in patients with advanced thoracic cancer treated with immune checkpoint inhibitor.

Eur J Cancer. 2024 Aug;207:114191. doi: 10.1016/j.ejca.2024.114191. Epub 2024 Jun 24.

Prognosis of immune checkpoint inhibitor-related myocarditis: Retrospective experience of a single institution.

Int Immunopharmacol. 2024 Jul 30;136:112385. doi: 10.1016/j.intimp.2024.112385. Epub 2024 Jun 7.

Role of Biomarkers in the Management of Immune-Checkpoint Inhibitor-Related Myocarditis.

Curr Cardiol Rep. 2023 Sep;25(9):959-967. doi: 10.1007/s11886-023-01915-5. Epub 2023 Jul 12.

Cardiac MRI Features and Prognostic Value in Immune Checkpoint Inhibitor-induced Myocarditis.

Radiology. 2022 Jun;303(3):512-521. doi: 10.1148/radiol.211765. Epub 2022 Mar 1.

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Circulation. 2023 Aug 8;148(6):473-486. doi: 10.1161/CIRCULATIONAHA.123.062405. Epub 2023 Jun 15.

Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.

Cell Rep. 2022 Nov 8;41(6):111611. doi: 10.1016/j.celrep.2022.111611.

Global Circumferential and Radial Strain Among Patients With Immune Checkpoint Inhibitor Myocarditis.

JACC Cardiovasc Imaging. 2022 Nov;15(11):1883-1896. doi: 10.1016/j.jcmg.2022.06.014. Epub 2022 Sep 14.

Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

J Am Coll Cardiol. 2018 Apr 24;71(16):1755-1764. doi: 10.1016/j.jacc.2018.02.037. Epub 2018 Mar 19.

引用本文的文献

Multimodal Imaging of Immune Checkpoint Inhibitor Myocarditis.

J Clin Med. 2025 Apr 21;14(8):2850. doi: 10.3390/jcm14082850.

Immune Checkpoint Inhibitor-Related Myocarditis, Myopathy, and More: Unraveling the Tangled Science of Immune-Related Adverse Events.

JACC CardioOncol. 2025 Apr;7(3):265-267. doi: 10.1016/j.jaccao.2025.03.004.

Immune Checkpoint Inhibitor-Related Myocarditis With or Without Concomitant Myopathy: Clinical Findings and Cardiovascular Outcomes.

JACC CardioOncol. 2025 Apr;7(3):252-264. doi: 10.1016/j.jaccao.2025.02.005. Epub 2025 Mar 17.

Characteristics, Incidence, and Management of Immune Checkpoint Inhibitors Related Cardiovascular Adverse Events in Real-World Practice-A Retrospective Study in Chinese Han Population.

Ther Clin Risk Manag. 2025 Feb 3;21:125-135. doi: 10.2147/TCRM.S477417. eCollection 2025.

本文引用的文献

Circulating biomarkers in the diagnosis and prognosis of immune checkpoint inhibitor-related myocarditis: time for a risk-based approach.

Front Cardiovasc Med. 2024 Feb 12;11:1350585. doi: 10.3389/fcvm.2024.1350585. eCollection 2024.

High-Sensitivity Troponin in Patients With Cancer: Sensitive But Not Specific.

JACC CardioOncol. 2023 Oct 17;5(5):610-612. doi: 10.1016/j.jaccao.2023.09.001. eCollection 2023 Oct.

Cardiac Troponins for Diagnosis and Prognostic Assessment of Immune Checkpoint Inhibitor Myocarditis and Myositis: The Emerging Importance of Peripheral Vision.

Circulation. 2023 Oct 10;148(15):1135-1137. doi: 10.1161/CIRCULATIONAHA.123.065988. Epub 2023 Oct 9.

Comparisons of multiple troponin assays for detecting chronic myocardial injury in the general population: redundant or complementary?

Eur Heart J. 2023 Jul 21;44(28):2606-2608. doi: 10.1093/eurheartj/ehad414.

Cardiomuscular Biomarkers in the Diagnosis and Prognostication of Immune Checkpoint Inhibitor Myocarditis.

Circulation. 2023 Aug 8;148(6):473-486. doi: 10.1161/CIRCULATIONAHA.123.062405. Epub 2023 Jun 15.

High-sensitivity troponins and mortality in the general population.

Eur Heart J. 2023 Jul 21;44(28):2595-2605. doi: 10.1093/eurheartj/ehad328.

Immune Checkpoint Inhibitor Therapy in Oncology: Current Uses and Future Directions: State-of-the-Art Review.

JACC CardioOncol. 2022 Dec 20;4(5):579-597. doi: 10.1016/j.jaccao.2022.09.004. eCollection 2022 Dec.

Biomarker Trends, Incidence, and Outcomes of Immune Checkpoint Inhibitor-Induced Myocarditis.

JACC CardioOncol. 2022 Dec 20;4(5):689-700. doi: 10.1016/j.jaccao.2022.11.004. eCollection 2022 Dec.

Atherosclerosis With Immune Checkpoint Inhibitor Therapy: Evidence, Diagnosis, and Management: State-of-the-Art Review.

JACC CardioOncol. 2022 Dec 20;4(5):598-615. doi: 10.1016/j.jaccao.2022.11.011. eCollection 2022 Dec.

Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.

Circulation. 2022 Jun 14;145(24):1764-1779. doi: 10.1161/CIRCULATIONAHA.121.058489. Epub 2022 Apr 7.